Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Over half of people with HIV and 17% of those newly diagnosed are 50 and older.
Novel therapies, improved technologies and a better understanding of the immune system could yield broad dividends.
Researchers showed that B cells evolve after COVID-19 vaccination to help improve protection against SARS-CoV-2 over time.
People whose HIV is locked away in “gene deserts” might be able to interrupt treatment without viral rebound.
Overall, vaccines are highly effective, but some folks are at risk for poorer response.
A second woman appears to have eliminated HIV naturally and may even be considered cured.
Evidence is growing that contracting SARS-CoV-2 is generally as effective as vaccination at preventing COVID-19.
Boosted by a Campbell Foundation grant, an HIV scientist is “exploring new ground” by studying these novel molecules.
Markers of immune activation rose, but only temporarily, around the transition to menopause.
About half of people hospitalized with COVID-19 had antibodies that could mistakenly attack the body’s own proteins and tissues.
Monkeys with SIV started generating specialized immune cells that may be able to hunt down and eliminate the virus from latent cells.
Experts call for heightened precautions and better, more intensive therapies for COVID-19 patients with weakened immune systems.
People with immune deficiency may not respond as well to vaccines but could still gain some protection.
An immune balance protocol for pre- and post-vaccination
We got COVID-19 vaccines in record time. Why are HIV vaccines taking so long?
A growing field of research suggests that the coronavirus unhinges the immune system more profoundly than previously realized.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.